文献速递乳腺癌

纯导管原位癌中免疫相关基因表达与乳腺癌复发风险的相关性研究

Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ.
PubMed 文献 · Eur J Cancer · 2024-04-12

该回顾性巢式病例对照研究纳入143例纯导管原位癌(DCIS)女性,比较70例后续发生同侧乳房事件(IBE,原位或浸润性)者与73例无IBE对照者(按年龄、肿瘤大小、治疗、激素受体/HER2状态及随访时间匹配)的395个免疫相关基因表达。发现8个免疫相关基因差异表达,其中MAGEA10表达、IFNA17和CBLB高表达在后续IBE(主要为浸润性)者中更常见,而IL3RA1、TAGAP、TNFAIP8表达及CCL2、LRP1高表达与较低IBE风险相关(FDR校正P<0.05)。作者认为这些结果经额外验证后可能改善DCIS风险分层和管理。

要点

  • 纯DCIS中MAGEA10表达及IFNA17、CBLB高表达在后续IBE(主要为浸润性)者中更常见(FDR校正P<0.05)。
  • IL3RA1、TAGAP、TNFAIP8表达及CCL2、LRP1高表达与较低IBE风险相关(FDR校正P<0.05)。
  • 作者认为这些免疫相关基因表达差异经额外验证后可能改善DCIS风险分层和管理。

核心结论

  • 该纯DCIS探索性分析显示,后续发生IBE(尤其浸润性IBE)与未发生IBE的女性之间免疫相关基因表达谱存在显著差异。
  • 作者认为这些结果经额外验证后可能改善DCIS患者的风险分层和管理。

研究设计与样本

  • 回顾性巢式病例对照研究,纳入143例纯DCIS女性,包括70例后续发生同侧乳房事件(IBE,原位或浸润性;病例)和73例无IBE对照。
  • 对照按年龄、肿瘤大小、治疗、激素受体/HER2状态及随访时间与病例匹配。
  • 从DCIS样本提取RNA,对395个免疫相关基因进行下一代测序基因表达分析。
  • 采用适用于巢式病例对照数据的加权Cox回归分析DCIS免疫相关基因表达与IBE的相关性。

主要发现

  • 8个免疫相关基因在病例与对照间差异表达。
  • MAGEA10表达(有 vs 无)及IFNA17、CBLB高表达水平(Q4 vs Q1)在后续发生IBE(主要为浸润性)的DCIS女性中更常见(FDR校正P<0.05)。
  • IL3RA1、TAGAP、TNFAIP8表达及CCL2、LRP1高表达水平与较低IBE风险相关(FDR校正P<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer with highly variable clinical behavior, but risk stratification is still challenging. We sought to identify immune-related gene expression signatures of pure DCIS associated with different risks of breast cancer recurrence. METHODS: A retrospective nested case-control study of 143 pure DCIS was performed including 70 women with subsequent ipsilateral breast event (IBE, in situ or invasive; cases) and 73 DCIS women with no IBE and matched for age, tumor size, treatment, hormone receptors/HER2 status, and follow-up time (controls). RNA was extracted from DCIS samples and subjected to next-generation sequencing gene expression analysis of 395 immune-related genes. Correlations between DCIS immune-related gene expression and IBE were analyzed using weighted Cox regression for nested case-control data. RESULTS: Eight immune-related genes were differentially expressed between cases and controls. MAGEA10 expression (present vs. absent) and high expression levels of IFNA17 and CBLB (Q4 vs. Q1) were observed more frequently in DCIS of women with subsequent IBE, mainly invasive (p-valueFDR < 0.05). Conversely, expression of IL3RA1, TAGAP, TNFAIP8, and high expression levels of CCL2 and LRP1 were associated with a lower risk of IBE (p-valueFDR < 0.05). CONCLUSION: This exploratory analysis of pure DCIS showed significant differences in immune-related gene expression profiles between women with and with no subsequent IBE, particularly as invasive IBE. These results, after additional validation, could improve risk stratification and management of DCIS patients.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Guerini-Rocco E, Bellerba F, Concardi A, et al. Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ. Eur J Cancer. 2024. PMID: 38615592. doi:10.1016/j.ejca.2024.114063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。